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Introduction 
In 2013 a group of international collaborators met to discuss 
what we know about the age and causes of death of people 
with intellectual disabilities (ID), the limitations of our existing 
data and how we could improve our knowledge in this 
respect. The collaboration has since been supported by a 
UK Economic and Social Research Council (ESRC) grant for 
a series of webinars and meetings from 2014 – 2017 to bring 
together academics, practitioners and policy-makers to 
discuss the development of internationally comparable 
mortality data in relation to people with ID. In this Special 
Edition, some of the contributors to those discussions set out 
the best evidence we have to-date about mortality data 
relating to people with ID.  
 
But first, let us review why an understanding of mortality data 
in general, and in relation to people with ID in particular, is 
such an important area of concern. 
 
Surveillance of patterns of mortality in vital statistics 
Analysis of mortality data to improve the health of the 
population has a long history. In the UK, William Farr used 
mortality data in the 1850s to stimulate debate about why 
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some cities were less healthy than others (Szreter 1991). At 
about the same time in the US, the first mortality report by 
the Massachusetts Sanitary Commission highlighted 
differences in age at death between farmers and mechanics, 
urging doctors to make more inquiries into the causes of 
death which prematurely shortened lives (Shattuck 1850). 
During the 19th and 20th centuries, as mortality data became 
available in industrialised countries, public health became 
transformed (Jha 2012).  Doll & Hill (1950) used mortality 
data to highlight a substantial increase in male deaths from 
lung cancer and hypothesised the causal association 
between smoking tobacco and lung cancer. In the US, 
Gottlieb et al. (1981) used routine mortality data from San 
Francisco to signal the start of the American HIV epidemic. 
Reliable and timely information on cause-specific mortality 
has now become a fundamental component of evidence-
based health policy development, implementation, and 
evaluation. In short, Jha (2012) argues that: ‘counting the 
dead is one of the world’s best investments to reduce 
premature mortality worldwide as it is one of the most robust 
ways to measure accurately the effectiveness of investments 
aimed at reducing child and adult mortality’ (p. 1. 
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Reducing premature mortality has been a priority nationally 
and internationally (World Health Organisation 2013; United 
Nations 2014) over recent years, but there are a number of 
ways in which what constitutes a ‘premature death’ might be 
determined, including: 
 Life expectancy at birth - the average survival time 
that members of a population can expect to live from 
the time of birth.  
 Life expectancy at age 75 – the additional number of 
years a person can expect to live if they reach the age 
of 75. This takes account of the fact that as people 
age, their life expectancy increases because they will 
have already have survived a myriad of potential 
causes of death.  
 Standardised Mortality Ratio (SMR) - the ratio of 
deaths observed in a particular group to those 
expected in a reference population of identical age 
structure. This provides a measure of how many more 
deaths than expected (if the death rate in the general 
population were applied) are observed in the 
population of interest. SMRs can be compared over 
time, between sexes and with equivalent statistics for 
other countries. 
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 Years of life lost - the total number of life years lost 
due to premature death. It is calculated by subtracting 
age at death from a threshold age, most commonly a 
threshold age for prematurity such as age 65 or 70, 
but the upper limit could also be life expectancy at 
birth or other variants. 
 
These measures of premature death rely on population-
based mortality data and in many developed countries, 
national vital registration systems are the major source of 
such data. These systems provide universal coverage of the 
population and operate continuously; official notification to 
the registration office that a death has occurred is usually a 
legal requirement before burial or cremation can take place, 
and information about age at death, gender, place and time 
of death and cause of death is collected about each death 
and then collated centrally at population level. Once such 
data has been collated, surveillance of patterns of mortality 
data can take place. 
 
Surveying patterns of mortality data is a reflexive process, 
identifying and responding to emerging trends and indicating 
where further analysis and action is required. Sutton (2012) 
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suggests that mortality surveillance should consist of two key 
elements. The first is the ongoing, systematic monitoring and 
analysis of mortality data. This requires that the entire 
population of a particular geographic area is included, and 
that the mortality data is accurate in terms of the 
characteristics of the people who have died and their causes 
of death. The second is that timely analysis of the data and 
dissemination of its findings will lead to actions being taken – 
either in relation to public health concerns raised by an 
understanding of the patterns of mortality, or in relation to 
the quality of the data itself.  
 
Mortality data about people with ID 
While information about the age and cause of death of the 
general population is routinely reported at national and 
cross-national levels, it is not usually possible to extract data 
about people with ID from this information.  As a result, we 
know little at national and international levels about the age 
and cause of death of people with ID and are missing an 
important source of information about the health of this 
vulnerable population. There are a number of reasons why 
this is the case:  
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 A lack of consistency in the identification of people 
with ID.  Definitions used to describe people with ID 
vary across countries and over time. At a local level in 
many countries, people with ID are identified via 
administrative criteria – so they are classed as having 
ID if they are eligible for ID services. However, 
eligibility criteria for such services vary, and many 
people, particularly those with mild ID, are unlikely to 
be included in such definitions. 
 Multiple coding options for the existence of ID. Glover 
& Ayub (2008), for example, identified 48 ICD10 
codes for medical conditions usually associated with 
ID, and 76 ICD10 codes for conditions sometimes 
associated with ID. 
 Incomplete and incompatible registers of people with 
ID. In Canada and the USA, for example, funding and 
provision of most services (education, health, and 
social services) is under provincial or state jurisdiction 
and there is no adequate national dataset(s) of people 
with ID. In England, registers are held by Local 
Authorities about the number of children with special 
educational needs whose primary need is because of 
ID, and by primary care doctors (GPs) of people with 
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ID registered with their practice, but there is a 
considerable disjoint between the registers (Emerson 
& Glover 2012). 
 A lack of recording of ID on Cause of Death 
certificates. World Health Organisation rules for 
completing the Cause of Death certificate requires a 
record of the sequential train of events leading to 
death, plus a record of any other diseases, injuries, 
conditions or events that contributed to the death but 
were not part of the direct sequence of events leading 
to death. In many cases, one’s ID may not cause or 
contribute to the person’s death, so would not 
therefore be recorded. In England, Tyrer & McGrother 
(2009) noted that only 41% of Cause of Death 
certificates of people known to have ID mentioned ID 
or an associated condition. The proportion in the 
English Confidential Inquiry into premature deaths of 
people with ID (CIPOLD) was 23%; here people with 
profound and multiple ID were identified on a Cause 
of Death certificate more frequently (58%) than 
people with mild ID (9%) (Heslop et al. 2013).   
 The rate of coding errors on Cause of Death 
certificates for people with ID. An additional factor 
9 
 
precluding the identification of people with ID from 
Cause of Death certificates is the rate of coding errors 
on these certificates for people with ID (Ouellette-
Kuntz 2005; Landes & Peek 2013). Landes & Peek 
(2013) identified 2,278 adults (aged 21 and over) who 
had ID recorded on their Cause of Death certificate 
but reported that 20% of these were coded 
erroneously by stating ‘mental retardation’ as the 
underlying cause of death. They concluded that 
diagnostic overshadowing may be obscuring the true 
cause of death of some people with ID. 
 
Even if we were to overcome each of these issues, the 
challenge of identifying premature death in people with ID 
remains. For example, life expectancy at birth measures 
using ‘average’ life expectancy are problematic in relation to 
some people with ID because they do not allow 
consideration of some early deaths given the presence of 
particular conditions associated with ID. As an illustration, it 
is unusual for someone born with Batten disease to live 
beyond their 30s, so all people with Batten disease would be 
identified as dying prematurely if the ‘average’ age of death 
of the general population was used as a threshold of 
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premature death, irrespective of the person’s potential life 
expectancy.  Similarly, life expectancy at age 75 measures 
are inappropriate for people with moderate and severe ID 
who are less likely to reach the age of 75 than those without 
ID (Patja et al. 2000). In addition, life expectancy 
calculations can only be performed with confidence with 
population-years at risk of 5,000 or more (Williams et al. 
2005), and unless internationally comparable data is used, 
the small number of people with ID likely to be in some 
subgroups is problematic.  
 
As most of the authors in this Special Edition indicate, using 
SMR provides a better measure of excess deaths in people 
with ID, although a comparatively small number of deaths of 
people with ID could give rise to a large amount of random 
variation, necessitating the aggregation of data over a 
number of years, or the combination of data from more than 
one geographic area. 
 
Responding to the challenges faced 
The challenge to obtain robust data about mortality of people 
with ID is considerable, but this Special Edition presents 
contributions from leading academics in a range of countries 
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about the data that is available in each country and how they 
are addressing the gaps in our knowledge about mortality of 
people with ID. We move from data relating to smaller 
geographical areas, through to national studies, and then to 
overviews of multiple studies within the same country. 
 
The first paper from Dieckmann et al. presents data about 
life expectancy of people with ID in Germany. The authors 
start with a helpful overview of international studies about 
mortality of people with ID from the USA, Finland, Western 
Australia and England. Overall, Dieckmann et al. suggest 
that although caution should be used when comparing the 
results of the studies, taken together they suggest that the 
life expectancy of people with ID has increased during the 
last two decades even though it remains below the life 
expectancy of the general population, gender-specific 
differences appear to be less significant than in the general 
population, and the severity of ID seems to be a strong 
influential factor in life expectancy.  
 
In Germany, to-date, there has been very little or no 
empirical research about the life expectancy and mortality of 
people with ID. Germany has a particular age profile of 
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people with ID because of the systematic killing of disabled 
people, including people with ID, in the Nazi era. As a result, 
the number of people with ID of retirement age in Germany 
is relatively small, and they are likely to be fairly resilient – or 
“healthy survivors” as Dieckmann et al. describe them, which 
can cause an overestimation of survival rates in older-age 
groups of people with ID.  
 
Dieckmann et al. report data from two regional population 
samples in Germany and calculated age-group-specific 
mortality rates by exponential regression analyses. They 
report an average life expectancy of men with ID to be 70.9 
years in one area, and 65.3 years in the other. The life 
expectancy of women with ID was 72.8 years in one area 
and 69.9 years in the other. The mortality rates of the 
younger age groups of people with ID were significantly 
higher than those of the general population, particularly up to 
the age of 45-52 for men (according to the sample 
population), and 52-53 for women. In the older populations 
at age 84 or more, the rates were almost the same as in the 
general population. 
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The second paper by Florio & Trollor compares mortality for 
people with ID to the general population in New South 
Wales (NSW), Australia. The authors have linked two 
sources of data: retrospective data (from 2005 onwards) 
from an administrative register of the NSW Department of 
Ageing Disability and Home Care which identifies people of 
all ages who are known to have an ID, and mortality data 
from the NSW Register of Births, Deaths and Marriages for 
the period June 1, 2005 to December 31, 2011. By using 
record linkage in this way the authors have been able to 
determine age and sex specific counts and rates of mortality 
for the cohort of people with ID aged 5-69 years old, who 
have previously received a state-funded ID service.  
 
Using the World Health Organization (WHO) standard age 
distribution for standardisation, Florio & Trollor report an Age 
Standardized Death Rate of 4.04 deaths per 1,000 in the ID 
cohort, compared with 1.58 deaths per 1,000 for the rest of 
the NSW population. The Age-Adjusted Death Rates are 
greater for the ID Cohort at all ages between 5 and 69 years 
old. The SMR for the ID Cohort was 3.15, but a significant 
difference was found between males (SMR 2.52) and 
females (SMR 4.26). The greater relative mortality in 
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females compared to males is noted to be different from the 
pattern in the general population of many countries where it 
is males that have greater relative mortality. It is an issue 
that the authors suggest should be explored further in future 
work and other cohorts. 
 
The third paper by Lauer & McCallion utilises information 
from four USA state disability service systems 
(Massachusetts, Connecticut, Ohio and Louisiana) that 
support people with intellectual and developmental 
disabilities (I/DD) to calculate average age of death and 
crude mortality rates. Each of these states has sufficient, 
well-established mortality reporting systems and similar I/DD 
service systems in order to facilitate aggregation and 
comparison of data. Contrasting information is provided by 
de-identified Medicaid claims data from the US State of New 
York. 
 
The authors suggest that people with I/DD continue to 
experience life expectancies that are approximately 20 years 
lower than the general population of the USA, crude 
mortality rates that are between 20% and 50% higher than 
the general population, and age-adjusted rates that are 
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about 80% higher. A notable gender difference was found, 
with females with I/DD experience greater disparities from 
the general population than males with I/DD (19.1 years 
difference in average age at death for females compared 
with 16.8 years difference for males). Such a gender 
difference, as Florio & Trollor (ibid.) also contend, requires 
greater investigation, and Lauer & McCallion suggest that a 
potential way forward in the USA would be for closer 
examination of Medicaid and medical claims data to better 
understand the influence on mortality of a range of possible 
contributory factors.  
 
The fourth paper in this collection is from McCarron and 
colleagues in Ireland. Ireland is interesting because it has a 
National Intellectual Disability Database (NIDD), an 
administrative database that includes details about all people 
with ID who are eligible for or receive services in the 
Republic of Ireland. Data is updated annually, and is 
available for almost 32,000 people from 2003-2012.  
 
The authors report an overall mortality rate in people with ID 
of 8.35%, but that this depended on age and severity of ID. 
Overall mortality in people with ID was four times higher than 
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in the general population, and they were, on average, dying 
19 years earlier than peers in the general population. In the 
youngest age group mortality was almost seven times higher 
in the ID population than the general population but this 
decreased with increasing age. The overall SMR for females 
was larger than for males, but gender differences diminished 
with increasing age. The average age at death was lowest 
for those with profound ID and increased with decreasing 
severity of ID.  
 
The authors suggest that between 2001 and 2003 there had 
been an increase in average age at death of approximately 
nine years and that although the increase had been 
sustained over the following decade, no further increases 
were noted during that time period. Some of the initial 
apparent improvements are likely to have been due to 
improved case finding, particularly of people with milder ID 
who are more likely to live longer lives. However, greater 
efforts are needs to more fully understand this pattern and 
the actions needed to sustain improvements in the life 
expectancy of people with ID. 
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The final two papers in this Special Edition provide 
overviews of a number of different studies within the same 
country. We start with a paper about mortality of people with 
ID in England by Heslop & Glover. They present the findings 
from four very different, recent sources of data about 
mortality of people with ID in England. 
 
From piecing this information together, and reanalysing 
some data in the light of information provided by another of 
the data sources, the authors draw conclusions that are 
similar to those of the other studies already reported in this 
Special Edition: that people with ID have a reduced life 
expectancy of 13-20 years in England when compared with 
the general population, and that the differences are greatest 
for women (compared with women in the general population) 
and for those with the most severe ID (compared with people 
with mild ID), although people with mild ID also died 
significantly younger than people in the general population. 
The SMRs of people with ID were twice that of the general 
population in England, and there was little indication of any 
reduction in this over time.  
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The authors comment that although each of the data 
sources contributes some information, none provide 
comprehensive national data about mortality of people with 
ID that is able to take account of the age and sex distribution 
of the population. Such data is currently lacking in England, 
but is urgently needed in order to better monitor the mortality 
of people with ID and the impact of any actions that are 
being taken to address the health inequalities faced by this 
population. In England, the most promising way forward will 
be to link data from GP registers of people with ID with 
national mortality data held by the Office for National 
Statistics but to-date, delays over the past two years have 
not yet seen this initiative come to fruition. 
 
The final paper is by Ouellette-Kuntz and colleagues in 
Canada who review three studies about mortality of people 
with intellectual and developmental disabilities in the 
provinces of Ontario and Manitoba. Taken together, the 
studies suggest that there is evidence of excess mortality in 
Canadians with intellectual and developmental disabilities, 
and that while excess mortality occurs at all ages, it is most 
pronounced in childhood and early adulthood. The authors 
attribute some of the excess mortality to comorbidities more 
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commonly seen in people with intellectual and 
developmental disabilities, and suggest that women may 
have a greater risk of death than men.  
 
The recent approach to link data mortality data with data that 
identifies people with intellectual and developmental 
disabilities has been a promising development in Manitoba 
by Shooshtari and Martens, and the development of similar 
work in Ontario holds exciting promise for better 
understanding the patterns of mortality in this population. It is 
an approach that is increasingly being recognized as offering 
significant potential in identifying the extent of premature 
deaths in people with intellectual and developmental 
disabilities, and changes over time. 
 
 
Together these papers present the current ‘state of play’ in 
each country of what we know about mortality of people with 
ID. They present the limitations of our existing data, and 
proposals for improving our knowledge in this area. With 
better information about mortality in this vulnerable 
population, we may be able to better understand how life 
expectancy and the health of the population can be 
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improved.  The study of mortality in the general population 
has moved far beyond the examination of demographic 
factors through innovative new models and methods to 
improve our understanding of sources of health risk and 
pathways through which health outcomes can be improved 
(Rogers & Crimmins).  Without better mortality information, 
the people with ID are unlikely to benefit from these methods 
and we may continue to struggle with little reliable evidence 
of health and social inequities. It is imperative that disability 
researchers and public health departments work together to 
improve access to and the quality of mortality information to 
facilitate monitoring of this population.   
 
The collection also focuses our intention, as ultimately, what 
we are working towards is the availability of evidence that 
will lead to measures being introduced to reduce premature 
and avoidable deaths in people with ID and ultimately 
improve the health of the population. It is this ambition that 
acts as the driver for much of the work being undertaken.  It 
is also the hope of this group that the information and 
methodologies presented in this collection may serve as a 
model for other countries to begin or improve their mortality 
surveillance of people with ID. 
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